Despite long-standing mumps vaccination programmes with high coverage in Europe, a majority of the countries analysed have in recent years experienced mumps outbreaks
On 30 May - 1 June 2012, ECDC and the WHO Regional Office for Europe (WHO/Europe) jointly held their second Annual Influenza Working Meeting in Warsaw, Poland. The main work undertaken by delegates in over 20 sessions and 70 talks and discussions was reviewing progress in the last 12 months and agreeing on the work for the coming year.
Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010 - Final Report of National Narcolepsy Study Steering Committee, Department of Health, Ireland
A rapid communication published on April 12th 2012 describes the early results of the annual multicentre case-control study undertaken by the ECDC sponsored I-MOVE consortium whose work is coordinated by an Epiconcept team
Preliminary results of European vaccine effectiveness study show decreased protective effect of the seasonal influenza vaccine in 2011/2012 season. ECDC Director Marc Sprenger calls for action.
A pair of linked papers from Finland concerning the above topic, one epidemiological and the second combining both clinical and epidemiological were published on March 28th in the open access journal, PLoS One.(1,2).
This study, strong of an almost complete follow-up of all children born in Denmark from 2003 to 2008, provides evidence that the DTaP-IPV-HiB vaccine is not associated to an overall increased risk of febrile seizures and epilepsy.
In this study, the authors have combined a household method and a school study design to assess VE against mumps as well as VE against mumps infectiousness by comparing secondary attack rates in households of vaccinated and unvaccinated cases.